Kousvelari et al., 2009 - Google Patents
Saliva-based diagnostic technologies: HighlightsKousvelari et al., 2009
- Document ID
- 3067836069957261093
- Author
- Kousvelari E
- McDevitt J
- Malamud D
- Wong D
- Walt D
- Publication year
- Publication venue
- Salivary Diagnostics
External Links
Snippet
In medicine, many different types of body fluids have been used for analysis to help in monitoring or diagnosing a particular condition or treatment regimen. Only a few analytes are usually measured; however, a univariate measurement is highly unlikely to provide …
- 210000003296 saliva 0 title abstract description 51
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3093147C (en) | An automated, cloud-based, point-of-care (poc) pathogen and antibody array detection system and method | |
| Mendoza et al. | High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA) | |
| Glynn et al. | CD4 counting technologies for HIV therapy monitoring in resource-poor settings–state-of-the-art and emerging microtechnologies | |
| Marie Dupuy et al. | Protein biochip systems for the clinical laboratory | |
| Hart et al. | Point‐of‐care oral‐based diagnostics | |
| Jokerst et al. | Programmable nano-bio-chip sensors: analytical meets clinical | |
| KR101518765B1 (en) | Method for detecting pathogens using microbeads conjugated to biorecognition molecules | |
| EP2932696A1 (en) | Assay apparatus | |
| US11313857B2 (en) | System and method for identifying and quantifying species with nanopores, using complexes of nanoparticles with carrier particles | |
| Mitsakakis et al. | Diagnostic tools for tackling febrile illness and enhancing patient management | |
| Zubair et al. | Microfluidic LIPS for serum antibody detection: demonstration of a rapid test for HSV-2 infection | |
| US20240241059A1 (en) | Cartridge, system, and method for molecular diagnostic reaction testing | |
| US20220299525A1 (en) | Computational sensing with a multiplexed flow assays for high-sensitivity analyte quantification | |
| CN103298952A (en) | Method for amplification-free nucleic acid detection on optofluidic chips | |
| Jokerst et al. | Programmable nano-bio-chips: multifunctional clinical tools for use at the point-of-care | |
| WO2019084051A1 (en) | An integrated microfluidic electrode array system for enzyme-linked immuno-sorbent assay for point- of-care detection of biomarkers | |
| US20070178514A1 (en) | System and method for analyzing a blood sample and disposable cartridge for use in this system or method | |
| Kuo et al. | Digital and absolute assays for low abundance molecular biomarkers | |
| US11366065B2 (en) | Point-of-care system and method for diagnosing acute febrile illness | |
| Duffy | Short keynote paper: single molecule detection of protein biomarkers to define the continuum from health to disease | |
| Kousvelari et al. | Saliva-based diagnostic technologies: Highlights | |
| Mohapatra et al. | Development of optical biosensor for diagnosis of microbial pathogens | |
| JP2022007854A (en) | System and method for automatic detection of cloud base detecting causal organism and antibody array by point of care (poc) | |
| Tortajada-Genaro et al. | Development and validation study of compact biophotonic platform for detection of serum biomarkers | |
| EP4220165A1 (en) | Method and device for the detection of traumatic brain injuries |